• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢性疾病的支出——2013年匈牙利糖尿病和肥胖症国家医疗保健支出估算

Expenditures Of Metabolic Diseases - An Estimation on National Health Care Expenditures of Diabetes and Obesity, Hungary 2013.

作者信息

Iski Gabriella, Rurik Sarolta E, Rurik Imre

机构信息

Faculty of Public health, Department of Family and Occupational Medicine, University of Debrecen, Debrecen, Hungary.

Independent macroeconomic adviser.

出版信息

Exp Clin Endocrinol Diabetes. 2019 Jan;127(1):62-67. doi: 10.1055/a-0630-0318. Epub 2018 Jul 2.

DOI:10.1055/a-0630-0318
PMID:29966152
Abstract

BACKGROUND

Obesity could be considered as the main consequence of unhealthy nutrition, responsible for many pathological alterations in human. Obese patients usually need more health care services. The aim of the study was to estimate the financial expenditures of health care provisions in Hungary, related to obesity and diabetes, as its main pathological consequence.

METHODS

Data of the Hungarian National Health Insurance Fund (NHIF) were collected for 2013, regarding finances of secondary care, hospital services, reimbursement for medications and healing aids of diabetic patients together with selected morbidities linked to obesity, based on the codes of the International Classification of Diseases (ICD) and calculated their population prevalence on the population-attributable fraction (PAF).

RESULTS

Financial data regarding diabetes care resulted in a 40,311 Million HUF (129 Million EUR) national fund expenses, beside a 7,173 Million HUF (23 Million EUR) contribution from patients. Estimated total health care expenditures related to obesity were 58,986 Million HUF (188 Million EUR) and the financial contribution of patients was calculated as 25,316 Million HUF (81 Million EUR). These data represent a 5.2% and 9.3% of the whole national health services, 16% and 30% of the whole drug-reimbursement budgets, respectively.

CONCLUSIONS

Although expenditures for some obesity related pathologies analyzed in this paper represent 0.28% of the national GDP, considering other morbidities and other patient's expenses, the real ratio could be between 0.5-1%. The increasing number of overweight and obese persons requires more focus in public health, higher awareness in the society and more governmental support.

摘要

背景

肥胖可被视为不健康营养的主要后果,它会导致人体出现许多病理改变。肥胖患者通常需要更多的医疗保健服务。本研究的目的是估算匈牙利与肥胖及其主要病理后果糖尿病相关的医疗保健支出。

方法

收集了匈牙利国家健康保险基金(NHIF)2013年的数据,这些数据涉及二级医疗保健、医院服务、糖尿病患者药物和治疗辅助器具的报销费用,以及与肥胖相关的特定疾病,这些数据基于国际疾病分类(ICD)编码,并计算了它们在人群归因分数(PAF)上的人群患病率。

结果

糖尿病护理的财务数据显示,国家基金支出为403.11亿匈牙利福林(1.29亿欧元),此外患者还贡献了71.73亿匈牙利福林(2300万欧元)。与肥胖相关的估计医疗保健总支出为589.86亿匈牙利福林(1.88亿欧元),患者的财务贡献计算为253.16亿匈牙利福林(8100万欧元)。这些数据分别占全国医疗服务的5.2%和9.3%,占整个药物报销预算的16%和30%。

结论

尽管本文分析的一些与肥胖相关疾病的支出占国家GDP的0.28%,但考虑到其他疾病和患者的其他费用,实际比例可能在0.5%-1%之间。超重和肥胖人群数量的增加需要公共卫生更多关注、社会更高的认识以及政府更多的支持。

相似文献

1
Expenditures Of Metabolic Diseases - An Estimation on National Health Care Expenditures of Diabetes and Obesity, Hungary 2013.代谢性疾病的支出——2013年匈牙利糖尿病和肥胖症国家医疗保健支出估算
Exp Clin Endocrinol Diabetes. 2019 Jan;127(1):62-67. doi: 10.1055/a-0630-0318. Epub 2018 Jul 2.
2
[The estimated economic burden of overweight and obesity in Hungary].[匈牙利超重和肥胖的估计经济负担]
Orv Hetil. 2014 Aug 31;155(35):1406-12. doi: 10.1556/OH.2014.29902.
3
[Health insurance reimbursement of dental care in Hungary].[匈牙利牙科护理的健康保险报销情况]
Fogorv Sz. 2012 Mar;105(1):3-8.
4
Socioeconomic costs of overweight and obesity in Korean adults.韩国成年人超重和肥胖的社会经济成本。
J Korean Med Sci. 2011 Dec;26(12):1533-40. doi: 10.3346/jkms.2011.26.12.1533. Epub 2011 Nov 29.
5
[Assessment of annual health insurance reimbursement for oncology drugs in Hungary].[匈牙利肿瘤药物年度医疗保险报销评估]
Magy Onkol. 2010 Dec;54(4):283-8. doi: 10.1556/MOnkol.54.2010.4.2.
6
[Health insurance pharmaceutical expenditures in Hungary].[匈牙利的健康保险药品支出]
Orv Hetil. 2019 Feb;160(Suppl 1):49-54. doi: 10.1556/650.2019.31394.
7
[Epidemiological disease burden and annual health insurance treatment cost of colorectal cancer in Hungary].[匈牙利结直肠癌的流行病学疾病负担及年度医疗保险治疗费用]
Orv Hetil. 2021 Mar 28;162(162 Suppl 1):14-21. doi: 10.1556/650.2021.32152.
8
[Health related costs of smoking from the viewpoint of the Health Insurance Fund in Hungary].[从匈牙利健康保险基金的角度看吸烟的健康相关成本]
Orv Hetil. 2012 Mar 4;153(9):344-50. doi: 10.1556/OH.2012.29280.
9
[Annual epidemiological and health insurance disease burden of pertrochanteric fractures in Hungary].[匈牙利转子间骨折的年度流行病学及健康保险疾病负担]
Orv Hetil. 2021 Mar 28;162(162 Suppl 1):46-53. doi: 10.1556/650.2021.32162.
10
The cost of obesity in Canada.加拿大肥胖问题的代价。
CMAJ. 1999 Feb 23;160(4):483-8.